Renowned virologist quits Govt panel on Covid-19 genome sequencing
'All of these measures have wide support among my fellow scientists in India. But they are facing stubborn resistance to evidence based policymaking. On April 30, over 800 Indian scientists appealed to the prime minister, demanding access to the data that could help them further study, predict and curb this virus,' the virologist said in the piece.;
New Delhi: Days after pointing out that scientists are facing 'stubborn resistance to evidence-based policymaking, noted virologist Shahid Jameel quit as the head of INSACOG, a central government panel that conducts genome sequencing of coronavirus.
Jameel announced his plan to step down in a meeting of INSACOG held on Friday, said two officials who were part of it.
Also Read: Prominent Indian-origin virologist in South Africa dies from coronavirus
Calls and messages to Jameel went unanswered.
An official said the virologist did not give any reason for why he was quitting.
Last week, Jameel had written a piece on the second wave of coronavirus in the 'New York Times'.
'All of these measures have wide support among my fellow scientists in India. But they are facing stubborn resistance to evidence-based policymaking. On April 30, over 800 Indian scientists appealed to the prime minister, demanding access to the data that could help them further study, predict and curb this virus,' he said in the piece.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.